Affiliation:
1. The Procter & Gamble Company, Mason, OH, USA
2. Silverstone Research Group, Las Vegas, NV, USA
Abstract
Objective: To evaluate the exposure frequency effect of 0.454% stannous fluoride (SnF2) toothpaste in controlling gingivitis. Methods: Two randomized controlled trials enrolled generally healthy adults with gingivitis. The study duration was 1 mo (study 1) and 3 mo (study 2). Gingivitis was assessed using the Löe-Silness Gingival Index (LSGI) at baseline, 1 mo (both studies), and 3 mo (study 2); bleeding scores were derived from the LSGI. Study groups consisted of positive control (twice-daily use of 0.454% SnF2 toothpaste), experimental group (brushing in the morning with SnF2 toothpaste and in the evening with 0.76% sodium monofluorophosphate [SMFP] toothpaste), and negative control (twice-daily use of SMFP toothpaste). The primary endpoint was number of bleeding sites. Results: Study 1 and study 2 each enrolled and randomized 90 participants; 86 and 89 participants, respectively, completed the trials. At baseline, the mean (SD) number of bleeding sites was 47.6 (18.54) in study 1 and 41.5 (17.84) in study 2. At 3 mo (study 2), the positive control produced 51.3% fewer bleeding sites, and the experimental group produced 32.5% fewer bleeding sites versus the negative control ( P < 0.001 for both). At 1 mo, the positive control produced 45.1% (study 1) and 45.8% (study 2) fewer bleeding sites versus the negative control ( P < 0.001 for both), and the experimental group produced 33.0% (study 1) and 24.8% (study 2) fewer bleeding sites, respectively, versus the negative control ( P ≤ 0.002 for both). The benefit was observed as early as 1 mo and was consistent with 3-mo results. Conclusion: This research is to our knowledge the first to demonstrate a gingivitis-reduction response effect for the frequency of bioavailable SnF2 toothpaste use, with maximum benefit from twice-daily use, followed by a single-daily exposure versus the negative control. Clinical trial registration numbers: NCT05916508 and NCT05916521. Knowledge Transfer Statement: The results of this study can be used by dental professionals to guide their recommendations for therapeutic toothpaste for gingival health. Emphasis on the importance of twice-daily brushing with bioavailable stannous fluoride dentifrice will help patients optimize gingival health benefits achieved via self-care.
Reference36 articles.
1. American Dental Association. 2023. American Dental Association: toothbrushes. Department of Scientific Information, Evidence Synthesis & Translation Research, ADA Science & Research Institute, LLC; [updated October 7, 2022; accessed September 6, 2023]. https://www.ada.org/resources/research/science-and-research-institute/oral-health-topics/toothbrushes#:~:text=The%20consensus%20recommendation%20is%20for,toothbrushes%20can%20be%20used%20effectively.
2. The Comparative Efficacy of Stabilized Stannous Fluoride/Sodium Hexametaphosphate Dentifrice and Sodium Fluoride/Triclosan/Copolymer Dentifrice for the Control of Gingivitis: A 6-Month Randomized Clinical Study
3. Beaglehole R, Benzian H, Crail J, Mackay J, King J, Lacey C, Wyse E. 2009. The oral health atlas: mapping a neglected global health issue. Brighton (UK): Dental Education Ltd & Myriad Editions. https://www.calameo.com/read/0052779815ab681b4af3e.
4. Total and free available fluoride in toothpastes in Brunei, Cambodia, Laos, the Netherlands and Suriname
5. The effects of bioavailable gluconate chelated stannous fluoride dentifrice on gingival bleeding: Meta‐analysis of eighteen randomized controlled trials